SCHEMBL22115984

SCHEMBL22115984

CC1(C)OC[C@H](C(O[Si](C)(C)C(C)(C)C)C(CN=[N+]=[N-])C2CC2)N1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15873310 1.00 — —
SCHEMBL29359270 0.90 SPHK1 (0.35) —
SCHEMBL21113895 0.87 — —
SCHEMBL15875677 0.87 — —
SCHEMBL15873305 0.87 — —
SCHEMBL15875678 0.87 — —
SCHEMBL20357915 0.85 — —
SCHEMBL15872754 0.85 — —
SCHEMBL20357914 0.85 — —
SCHEMBL16504804 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4186897-A1 PYRIDINECARBOXAMIDE COMPOUND USEFUL AS PIM KINASE INHIBITOR Incyte Holdings Corporation (US) 2023-05-31 — — EP disclosed
EP-3670506-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS Incyte Holdings Corporation (US) 2020-06-24 — — EP disclosed
Send feedback